Navigation Links
High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers

DALLAS, March 5 /PRNewswire-USNewswire/ -- Yesterday's Supreme Court ruling against preemption is disastrous for patient access to necessary medicines and research for new therapies, and clearly elevates trial lawyers and local juries as the de facto authority on drug safety.

The high court has decided that federal law does not preempt state law in matters of drug safety, and consequently, a flood of frivolous liability lawsuits will cause patients to lose access to critical new medicines.

"The victors in this decision claim that eliminating preemption would make drug companies more rigorous in ensuring their drugs are safe; unfortunately, it would more likely make companies invention-averse," said Institute for Policy Innovation (IPI) resident scholar and health care expert Dr. Merrill Matthews.

Without preemption, drug makers will be more risk averse, as they grind themselves for legal battles. The result is that patients will lose access to necessary medicines and research into new cures will decline.

"This is a win-win situation for trial lawyers, and a lose-lose for patients," said Matthews. "Lawsuits are expensive, and even the threat of baseless litigation can cause pharmaceutical firms to slow down and even stop creating and developing new products.

"Plaintiff Diana Levine's story is tragic, and the physician's assistant who misused the clearly labeled drug should be, and was, held accountable. But it's hard to see how the maker of the drug could be at fault," said Matthews.

Without a strong preemption principle, average Americans who serve on local juries will be asked to overrule the government scientists and medical experts who oversee the drug-approval process.

"Trial lawyers know that jurors are ill-suited to evaluate the merits of drug warning labels, which is exactly why they're behind this effort. Without preemption we'll see a surge of frivolous lawsuits against pharmaceutical companies and other manufacturers." said Matthews.

The Institute for Policy Innovation is an independent, non-profit public policy organization based in Dallas, Texas. Dr. Merrill Matthews is available for interview by contacting Erin Humiston at (972) 874-5139, or

SOURCE Institute for Policy Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
3. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
4. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
5. Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
6. Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research
7. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
8. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
9. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
10. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights
11. ALLs Judie Brown: Supreme Court is Wrong on Contraception Ruling
Post Your Comments:
(Date:11/27/2015)... , ... November 28, 2015 , ... There is only ... outperform our billings from last year? , This question has not been an easy ... coming to the retirement age and the younger workforce don’t share the same discipline ...
(Date:11/27/2015)... ... 2015 , ... According to an article published November 15th by ... handling security in light of the recent terrorist attacks in Paris, other cities are ... an attack from reaching U.S. soil. Especially around special events that may be high-profile ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of “Supporting ... Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 ... through a vast social media strategy and across a network of top news ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the Radiology ... Building Better Radiology Marketing Programs meeting will showcase some of the best ... at Caesars Palace in Las Vegas with a pre-conference session on a collaborative ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)...  ARKRAY USA , Inc., a ... demonstrating the accuracy of its blood glucose meter systems. ... Diabetes and Cardiovascular Disease in Los Angeles ... ® 01 meter and the Assure ® ... to accurately measure glucose levels in blood is essential ...
Breaking Medicine Technology: